Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 57.56
+5.56 (10.69%)
At close: May 21, 2026
SHA:688192 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -667.09 | -764.05 | -845.96 | -1,108 | -736 | -669.88 |
Depreciation & Amortization | 66.88 | 66.88 | 66.37 | 65.58 | 58.43 | 53.72 |
Other Amortization | 9.69 | 9.69 | 10.65 | 7.1 | 4.64 | 1.86 |
Loss (Gain) From Sale of Assets | -0 | -0 | - | 0.01 | -0.02 | - |
Loss (Gain) From Sale of Investments | -25.33 | -25.33 | -14.45 | -22.52 | -42.16 | -2.37 |
Stock-Based Compensation | - | - | - | - | 27.89 | 61.97 |
Provision & Write-off of Bad Debts | 1.17 | 1.17 | -0.12 | 0.4 | -0.02 | 0 |
Other Operating Activities | -64.98 | 100.79 | 64.32 | 6.6 | -5.17 | 9.4 |
Change in Accounts Receivable | -114.03 | -114.03 | 23.7 | -57.22 | -0.72 | -17.93 |
Change in Inventory | 7.17 | 7.17 | -20.64 | -18.4 | -5.07 | - |
Change in Accounts Payable | 129.38 | 129.38 | 65.6 | -38.33 | 94.83 | 70.93 |
Change in Other Net Operating Assets | - | - | - | 196.61 | - | - |
Operating Cash Flow | -657.14 | -588.32 | -650.53 | -967.88 | -603.37 | -492.28 |
Capital Expenditures | -129.55 | -170.47 | -137.58 | -32.13 | -73.78 | -8.98 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | 0 | 0 | - |
Investment in Securities | -1,034 | -1,028 | 99.5 | 643.32 | 458.34 | -1,620 |
Other Investing Activities | - | - | - | - | - | 1.68 |
Investing Cash Flow | -1,163 | -1,199 | -38.07 | 611.19 | 384.56 | -1,627 |
Short-Term Debt Issued | - | - | - | - | - | 19.54 |
Long-Term Debt Issued | - | 810.72 | 963.36 | 338.23 | - | - |
Total Debt Issued | 806.45 | 810.72 | 963.36 | 338.23 | - | 19.54 |
Short-Term Debt Repaid | - | - | - | - | - | -19.54 |
Long-Term Debt Repaid | - | -740.81 | -233.51 | -26.32 | -22.14 | -18.01 |
Total Debt Repaid | -808.45 | -740.81 | -233.51 | -26.32 | -22.14 | -37.55 |
Net Debt Issued (Repaid) | -2 | 69.91 | 729.85 | 311.91 | -22.14 | -18.01 |
Issuance of Common Stock | 1,793 | 1,793 | 158.27 | 1.25 | 3.75 | 2,022 |
Common Dividends Paid | -31.44 | -32.89 | -20.55 | -3.38 | - | - |
Other Financing Activities | 32.42 | -1.76 | -0.55 | -1.53 | -14.88 | -22.45 |
Financing Cash Flow | 1,792 | 1,829 | 867.01 | 308.25 | -33.26 | 1,981 |
Foreign Exchange Rate Adjustments | -0.59 | -0.39 | -2.45 | 0.97 | 9.52 | -6.33 |
Net Cash Flow | -28.81 | 41.26 | 175.96 | -47.47 | -242.56 | -144.78 |
Free Cash Flow | -786.69 | -758.79 | -788.1 | -1,000 | -677.15 | -501.26 |
Free Cash Flow Margin | -88.00% | -94.72% | -218.98% | -1095.44% | - | -4873.51% |
Free Cash Flow Per Share | -1.73 | -1.70 | -1.90 | -2.46 | -1.67 | -1.39 |
Cash Interest Paid | - | - | - | - | - | 0.05 |
Cash Income Tax Paid | 59.88 | 40.36 | 20.7 | -5.18 | -68.69 | -25.17 |
Levered Free Cash Flow | -619.74 | -533 | -427.28 | -596.9 | -468.46 | -234.15 |
Unlevered Free Cash Flow | -598.74 | -512.01 | -411.15 | -592.17 | -465.75 | -232.23 |
Change in Working Capital | 22.52 | 22.52 | 68.66 | 82.66 | 89.05 | 53.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.